Overlooked thrombophilia in a younger woman with recurrent deep vein thrombosis
Ugeskrift for Læger · 26.10.2026 · 1-4
DOI: 10.61409/v03260219 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ugeskrift for Læger, online erschienen am 26.10.2026. Verfasst von Nikolaj Julian Skrøder Nytoft und 1 weiteren Autor:innen.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Antithrombin is the most important endogenous anticoagulant, and hereditary antithrombin deficiency increases the risk of venous thromboembolism (VTE). In this case, we present a young woman with recurrent VTE and factor V Leiden heterozygosity but normal antithrombin activity. SERPINC1 sequencing revealed heterozygosity for SERPINC1:p.Val30Glu (AT Dublin), which is associated with transient antithrombin deficiency and mildly increased risk of VTE. Transient antithrombin deficiency can, in some cases, affect VTE management but may be missed unless SERPINC1 is sequenced.
Zitieren
APA
Nytoft, N. J. S., & Larsen, E. L. (2026). Overlooked thrombophilia in a younger woman with recurrent deep vein thrombosis. Ugeskrift for Læger, 1-4. https://doi.org/10.61409/v03260219
Vancouver
Nytoft NJS, Larsen EL. Overlooked thrombophilia in a younger woman with recurrent deep vein thrombosis. Ugeskrift for Læger. 2026:1-4. doi:10.61409/v03260219
BibTeX
@article{Nytoft2026,
author = {Nytoft, Nikolaj Julian Skrøder and Larsen, Emil List},
title = {Overlooked thrombophilia in a younger woman with recurrent deep vein thrombosis},
journal = {Ugeskrift for Læger},
year = {2026},
pages = {1--4},
doi = {10.61409/v03260219}
}
EUVIMED